Jae H. Jung
Songnam, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review, evidence-mapping, and meta-analysis.
Journal: Therapeutic advances in medical oncology
Published: October 22, 2022
Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer.
Journal: Frontiers in oncology
Published: September 21, 2022
Prediction model using clinical factors for radiation exposure during endoscopic retrograde cholangiopancreatography.
Journal: Journal of gastroenterology and hepatology
Published: December 29, 2021
Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis.
Journal: Gut and liver
Published: July 26, 2021
Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment.
Journal: Cancers
Published: September 25, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026